Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review.

Brigida Anna Maiorano Mauro Francesco Pio MaioranoDavide CiardielloAnnamaria MaglioneMichele OrdituraDomenica LorussoEvaristo Maiello

Published in: Cancers (2022)

Immunotherapy represents an appealing strategy for patients with advanced CC, as 2 out of 3 patients seem to respond to ICIs. PD-L1 status might be an indicator of response without impacting survival.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
small cell lung cancer
prognostic factors
free survival